echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The third batch of national price limit and the forecast, ready to go up!

    The third batch of national price limit and the forecast, ready to go up!

    • Last Update: 2020-07-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: National price limit and volume forecast!national product price limit estimatethis national price forecast, mainly based on two points
    1, the evaluation of the product counterpart enterprise, the rule of the historical bid price2, the same common name, the same specifications of all manufacturers bid price referencetable 1: the third batch of national product stakes corresponding specifications may limit price (not considering the difference price)(information source:special note: retail does not count, some channels do not countTable 2: the third batch of national products corresponding specifications may purchase(source of information: Fengyun medicine talk finishing)feng yun brief review:1, lie win: in the process of sorting the data found that some products are lying in, really strength and luck, congratulations, congratulations!2, part of the lack of rules: although the country in the amount of the report is 86 rules, but the final announcement of the time may be less than 86, in 80 or so of the standard, even less than 80, wait and see!3, more than 10 billion: according to the current forecast price and the volume, the overall amount reached nearly 18 billion yuan;according to the collection of health insurance fund balance retention incentive policy, then the entire health care system can get more than 4 billion yuan of incentive "funds." The non-winning has a greater impact4, for reference only: data for past data reference, such as Moxisha xing injection statistics will not count the number of small needles? Most of the sales of some products are in retail and channels, this part of the data is difficult to statistically accurate; 5, just started: there is a phenomenon, is that some products belong to the super-rise period, at this time the health insurance fund balance how to calculate? These products must be used in excess, such as the left ethyl lasitan two dosage forms, for Grillo, Vigretin, apixaban, linamine don't know how the health care bureau is thinking about this?
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.